Search

Search Constraints

You searched for: Author/Creator Collini, P.

Search Results

1. Activity of axitinib in progressive advanced solitary fibrous tumour: Results from an exploratory, investigator-driven phase 2 clinical study. (January 2019)

2. Corrigendum to "SELNET clinical practice guidelines for bone sarcoma" Critical reviews in oncology/hematology, vol. 174 (2022), 1–10. (December 2022)

3. Corrigendum to "SELNET clinical practice guidelines for soft tissue sarcoma and GIST" [Cancer Treat. Rev. 102 (2021) 102312]. (April 2023)

4. Is There a Role for FDG-PET for the Assessment of Treatment Efficacy in Wilms' Tumor? A Case Report and Literature Review. (1st October 2013)

5. ISG15 as a prognostic biomarker in solitary fibrous tumour. (October 2022)

6. Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour. (May 2017)

7. Resectable extra-pleural and extra-meningeal solitary fibrous tumours: A multi-centre prognostic study. Issue 7 (July 2016)

8. SELNET clinical practice guidelines for bone sarcoma. (June 2022)

9. SELNET clinical practice guidelines for soft tissue sarcoma and GIST. (January 2022)

10. Tazemetostat and doxorubicin in patient-derived preclinical models of epithelioid sarcoma (ES). (October 2022)